Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:gamma_delta_T_cell
T cell subtype |
| gptkbp:activatedBy |
microbial metabolites
bromohydrin pyrophosphate (BrHPP) isopentenyl pyrophosphate (IPP) |
| gptkbp:compatibleWith |
MHC presentation for antigen recognition
|
| gptkbp:cytotoxicTo |
tumor cells
infected cells |
| gptkbp:doesNotRecognize |
peptide antigens
|
| gptkbp:expressedIn |
gptkb:NKG2D
gptkb:CD3 CD16 T cell receptor Vγ9 T cell receptor Vδ2 |
| gptkbp:features |
primates
|
| gptkbp:firstDescribed |
1980s
|
| gptkbp:foundIn |
lymphoid tissues
epithelial tissues human peripheral blood |
| gptkbp:hasRole |
innate immunity
tumor surveillance infection response |
| https://www.w3.org/2000/01/rdf-schema#label |
Vγ9Vδ2 T cells
|
| gptkbp:involvedIn |
autoimmune diseases
inflammatory responses antimicrobial defense |
| gptkbp:proportionOfTCells |
1-10% in human peripheral blood
|
| gptkbp:recognizedBy |
non-peptide antigens
phosphoantigens |
| gptkbp:secretes |
gptkb:interferon-gamma
gptkb:tumor_necrosis_factor-alpha |
| gptkbp:target |
immunotherapy research
|
| gptkbp:bfsParent |
gptkb:CD277
|
| gptkbp:bfsLayer |
8
|